← Back
$NAMS All transactions

NewAmsterdam Pharma Co N.V.

▼ SELL 10b5-1 Plan

$ Value

$941K

Shares

44,025

Price

$21

Filed

Jul 17

Insider

Name

Kling Douglas F

Title

Chief Operating Officer

CIK

0001699022

Roles

Officer

Transaction Details

Transaction Date

2025-07-15

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

47,544

Footnotes

This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.02 per share to $22.01 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.02 per share to $22.22 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.88 per share to $21.56 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction. | The option was granted on January 1, 2023. 25% of the shares underlying the option vested on the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.

Filing Info

Accession No.

0000950170-25-096665

Form Type

4

Issuer CIK

0001936258

Kling Douglas F's History

Date Ticker Type Value
2025-07-16 NAMS M $556K
2025-07-16 NAMS $1.1M
2025-07-16 NAMS M $0
2025-07-15 NAMS M $519K
2025-07-15 NAMS $941K
2025-07-15 NAMS $78K
2025-07-15 NAMS M $0
2025-06-16 NAMS M $781K
2025-06-16 NAMS M $239K
2025-06-16 NAMS $1.6M

Other Insiders at NAMS (90d)

Insider Bought Sold Last
Kooij Louise Frederika
Chief Accounting Officer
$4.8M 2026-01-28